Advertisement
YOU ARE HERE: LAT HomeCollectionsLumigan Drug
IN THE NEWS

Lumigan Drug

FEATURED ARTICLES
BUSINESS
October 24, 2000 | From Bloomberg News
Allergan Inc., an Irvine maker of drugs used in eye and skin care, said Monday a late-stage trial found its once-a-day glaucoma drug Lumigan more effective than a commonly used twice-a-day medicine at treating a symptom of the eye disorder. The company's stock rose $4, or 5.3%, to $80.19 a share on the New York Stock Exchange. The shares have risen 61% this year. Allergan said Lumigan decreased pressure within patients' eyes significantly more than twice-daily timolol, made by Merck & Co.
ARTICLES BY DATE
BUSINESS
October 24, 2000 | From Bloomberg News
Allergan Inc., an Irvine maker of drugs used in eye and skin care, said Monday a late-stage trial found its once-a-day glaucoma drug Lumigan more effective than a commonly used twice-a-day medicine at treating a symptom of the eye disorder. The company's stock rose $4, or 5.3%, to $80.19 a share on the New York Stock Exchange. The shares have risen 61% this year. Allergan said Lumigan decreased pressure within patients' eyes significantly more than twice-daily timolol, made by Merck & Co.
Los Angeles Times Articles
|